SecBot SecBot
PRESS-RELEASE ·Filed Jul 13, 2026

ERAS

Erasca, Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed4mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight ▼ Bearish

The rapid pricing and significant dilution suggest Erasca needed cash urgently, possibly ahead of a material R&D milestone or to extend runway into a binary catalyst. Traders should watch for any pipeline updates (data readouts, IND filings) in the coming weeks that could explain the timing. The large raise at near-market (no discount disclosed) partly mitigates the bearish signal, but the ~20% dilution is meaningful. Monitor secondary trading for stabilization after the July 15 close.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$19.50
T+0 close · Jul 13, 2026 · via day close
Latest settled
−27.59%
T+60 · $14.12
Vs SPY
−30.97%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 14 $19.50entry
  2. T+1 · 4mo ago +9.03%α +8.63% · $21.26
  3. T+5 · 4mo ago −3.49%α −2.19% · $18.82
  4. T+20 · 3mo ago −6.10%α −8.59% · $18.31
  5. T+60 · 6w ago −27.59%α −30.97% · $14.12
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Erasca has priced an upsized public offering of 31,428,572 shares at $17.50/share, expecting ~$550M in gross proceeds. The offering represents significant dilution (roughly 20% of pre-offer shares) and closed the same day the S-3 was filed, suggesting urgency to raise capital. Given the company's $5.8B market cap and the large raise, this is a material event that signals either aggressive pipeline funding or potential near-term cash needs.

Key Financial Metrics

Deal Value
$550.0M

Key Facts

  • 31,428,572 shares offered at $17.50/share
  • Expected gross proceeds of approximately $550.0 million
  • Underwriters have a 30-day option for up to an additional 4,714,285 shares
  • S-3 shelf registration filed and became effective on July 13, 2026 (same day as pricing)
  • Joint book-runners: J.P. Morgan, Morgan Stanley, Jefferies, Evercore ISI
  • Offering expected to close July 15, 2026
  • Proceeds to fund R&D of product candidates and for working capital

Financial Impact

Approximately $550M in gross proceeds from issuance of ~31.4M new shares. Based on pre-offer share count (implied from market cap / price), dilution is roughly 20%.

dilutioncashPositionworkingCapital

Risk Factors

  • Significant dilution (~20%) to existing shareholders
  • Offering size was upsized, suggesting strong demand but also larger capital needs
  • Proceeds use is vague ('research and development' and 'working capital'), raising uncertainty about specific deployment
  • The S-3 and pricing occurred the same day, indicating a pre-planned accelerated offering

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3326554

Track record

26 reports on ERAS

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +95.35% at T+60 after the Apr 27, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $15.21 Now $15.11 −0.66% settles Feb 12
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.31 Now $15.11 −1.31% settles Feb 12
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.35 Now $15.11 −1.56% settles Feb 12
  4. Nov 12, 20264d ago Press Release Neutral 4/10 Entry $15.66 Now $15.11 −3.51% settles Feb 11
  5. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $14.64 Now $15.11 +3.21% settles Feb 1
  6. Oct 16, 20264w ago 8-K Neutral 2/10 Entry $13.39 Now $15.11 +12.85% settles Jan 13
  7. Aug 24, 202612w ago 8-K Bullish 5/10 Entry $17.60 Now $15.11 −14.15% settles Nov 17
  8. Aug 17, 202613w ago 144 Neutral 3/10 Entry $18.28 to $15.61 Now $15.11 −17.34% ▼ −14.61% −11.84% vs SPY
  9. Aug 13, 202613w ago Institutional Cluster Bullish 6/10 Entry $17.86 to $14.41 Now $15.11 −15.40% ▼ −19.32% −13.84% vs SPY
  10. Aug 12, 202613w ago 3 Neutral 2/10 Entry $17.86 to $14.41 Now $15.11 −15.40% ▼ −19.32% −13.84% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 9h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 13, 2026